Literature DB >> 25725930

A meta-analysis of resected metachronous second non-small cell lung cancer.

Masatsugu Hamaji1, Syed Osman Ali2, Bryan M Burt3.   

Abstract

This meta-analysis was designed to determine the effect of surgical treatment on overall survival of patients treated surgically for a second non-small cell lung cancer (NSCLC) that occurred after resection of an initial NSCLC. PubMed and Scopus databases were queried. Nine studies were identified. Meta-analyses revealed pooled operative mortality of 7% for the second resection, pooled 5-year overall survival of 46% after resection of the second NSCLC, and 79% after resection of the first NSCLC. These results suggest that surgical resection can be considered for patients who have a second primary NSCLC after resection of an initial lung cancer.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25725930     DOI: 10.1016/j.athoracsur.2014.11.033

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Clinicopathological characteristics of colorectal metastases from lung cancer: systematic review of the case reports in the Japanese literature.

Authors:  Yoshinori Kikuchi; Hideaki Shimada; Kazutoshi Isobe; Ryo Shimizu; Munehiro Wakabayashi; Kazuhisa Yamaguchi; Yoshinori Igarashi
Journal:  Int Cancer Conf J       Date:  2021-07-19

2.  Clinical outcomes of patients with metachronous second primary lung adenocarcinomas.

Authors:  Heng Zhao; Haitang Yang; Ke Han; Jianlin Xu; Feng Yao; Yang Zhao; Liwen Fan; Haiyong Gu; Zhenya Shen
Journal:  Onco Targets Ther       Date:  2017-01-10       Impact factor: 4.147

3.  Role of chemotherapy for survival in patients with second primary non-small cell lung cancer.

Authors:  Zhile Wang; Yijun Wu; Li Wang; Liang Gong; Chang Han; Fucun Xie; Shanqing Li
Journal:  Thorac Cancer       Date:  2020-12-09       Impact factor: 3.500

4.  Prognostic Nomogram and Therapeutic Option of Cancer-Specific Death in the Patients with Metachronous Second Primary Lung Cancer.

Authors:  Jiahui Wang; Zhen Chen; Daokui Xia; Xinyu Song; Zhigang Hu
Journal:  J Oncol       Date:  2022-01-18       Impact factor: 4.375

5.  Surgical treatment to multiple primary lung cancer patients: a systematic review and meta-analysis.

Authors:  Ting-Fei Chen; Chun-Ying Xie; Bing-Yu Rao; Shi-Chao Shan; Xin Zhang; Bo Zeng; Yi-Yan Lei; Hong-He Luo
Journal:  BMC Surg       Date:  2019-12-03       Impact factor: 2.102

6.  Using Liposomes to Alleviate the Toxicity of Chelerythrine, a Natural PKC Inhibitor, in Treating Non-Small Cell Lung Cancer.

Authors:  Jiahui Wang; Yijie Song; Ning Zhang; Ning Li; Congying Liu; Bing Wang
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.